SCHEMBL10104049

SCHEMBL10104049

CC[n+]1ccccc1/C=C/c1ccc(NCCSSCCNc2ccc(/C=C/c3cccc[n+]3CC)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.55
KMT2A Q03164 7/20 0.55
MEN1 O00255 5/20 0.55
NPC1 O15118 5/20 0.55
ALDH1A1 P00352 2/20 0.55
MAPT P10636 2/20 0.55
HTT P42858 2/20 0.55
STAT3 P40763 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
KDM4E B2RXH2 2/20 0.48
KDM4A O75164 2/20 0.42
KDM2A Q9Y2K7 2/20 0.42
APOBEC3A P31941 2/20 0.39
APOBEC3G Q9HC16 2/20 0.39
GFER P55789 1/20 0.39
PABPC1 P11940 1/20 0.34
EIF4H Q15056 1/20 0.34
APP P05067 3/20 0.33
POLB P06746 4/20 0.32
NSD2 O96028 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14393529 0.90 RAB9A (0.56) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL1825824 0.85 RAB9A (0.40) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL1825826 0.85 RAB9A (0.40) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL10104052 0.84 RAB9A (0.50) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL12657240 0.81 MEN1 (0.63) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL21278026 0.80 KDM4A (0.42) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL10104110 0.80 MEN1 (0.41) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL19649311 0.80 MEN1 (0.51) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL10104138 0.80 KDM4E (0.45) RAB9AKMT2AMEN1NPC1ALDH1A1
SCHEMBL10104068 0.78 KDM4A (0.38) RAB9AKMT2AMEN1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004759-B1 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE ORÉAL L (FR) 2016-05-11 EP disclosed
EP-2781556-A1 Method of colouring and lightening keratin materials in the presence of a reducing agent comprising a fluorescent disulphide dye L'Oréal (FR) 2014-09-24 EP disclosed
US-8097044-B2 Hair compositions comprising at least one disulfide direct dye and at least one alkaline hydroxide agent and simultaneous hair shaping and dyeing processes L'OREAL S.A. (FR) 2012-01-17 US disclosed
US-8038731-B2 hair dyes contains naphthylimide thiol or disulphide groups; resistant and visible lightening effect on dark keratin fibres; cosmetics L'OREAL S.A. (FR) 2011-10-18 US disclosed
US-20090313769-A1 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE L'OREAL S.A. (FR) 2009-12-24 US disclosed
US-20090126755-A1 Hair compositions comprising at least one disulfide direct dye and at least one alkaline hydroxide agent and simultaneous hair shaping an dyeing processes L'OREAL S.A. (FR) 2009-05-21 US disclosed
EP-2018847-A1 Hair composition comprising at least one direct disulfide dye and at least one alkali hydroxide agent and method of simultaneous styling and dyeing. L'Oreal (FR) 2009-01-28 EP disclosed
WO-2007110534-A2 DYEING COMPOSITION COMPRISING A THIOL/DISULPHIDE FLUORESCENT COLORANT HAVING AN EXTERNAL CATIONIC CHARGE, AND METHOD FOR LIGHTENING KERATIN MATERIALS USING SAID COLORANT L'ORÉAL (FR) 2007-10-04 WO disclosed
WO-2007110542-A2 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE L'OREAL (FR) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090126755-A1 Hair compositions comprising at least one disulfide direct dye and at least one alkaline hydroxide agent and simultaneous hair shaping an dyeing processes KRT18, DSG1, ALPG RAB9A 4038/4885KMT2A 1006/4885MEN1 3833/4885
US-20090313769-A1 METHOD OF DYEING AND LIGHTENING KERATIN MATERIALS IN THE PRESENCE OF A REDUCING AGENT COMPRISING A FLUORESCENT DISULPHIDE DYE KRT18, DSG1, KRTCAP2 RAB9A 3829/4885KMT2A 1186/4885MEN1 3694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.